Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
High-Frequency Jet Ventilation or Vocal Cord Resection
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine whether deep neuromuscular blockade provides better surgical conditions than moderate neuromuscular blockade in patients undergoing vocal cord resections requiring jet ventilation.

Provided treatments

  • Drug: Rocuronium bromide 0.5 mg/kg
  • Drug: Rocuronium bromide 1.0 mg/kg
  • Drug: Sugammadex sodium 2 mg/kg
  • Drug: Sugammadex sodium 4 mg/kg
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02888067. The sponsor of the trial is Thomas Schricker and it is looking for 30 volunteers for the current phase.
Official trial title:
Surgical Conditions During Vocal Cord Surgery Requiring Jet Ventilation in Patients With Moderate vs. Deep Neuromuscular Block